Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA Approves Pembrolizumab for Merkel Cell Carcinoma

americanpharmaceuticalreviewDecember 21, 2018

Tag: FDA , pembrolizumab , Merkel , cell carcinoma

PharmaSources Customer Service